Laboratory of targeted gene mapping for predictive oncological diagnostics of Czech Center Digital Genomics (Q11526)

From EU Knowledge Graph
Revision as of 15:09, 22 October 2020 by DG Regio (talk | contribs) (‎Removed claim: summary (P836): The TGM project aims at creating a new dedicated human genome mapping site for collaborative development and clinical research on new products for determining the early stages of cancer involving circulating blood cells. We are planning to make a major contribution to the development of the Thanotics in the Czech Republic, i.e. diagnostics based on diagnostics that lead to the personalisation of health care, efficiency gains and targeted thera...)
Jump to navigation Jump to search
Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
Laboratory of targeted gene mapping for predictive oncological diagnostics of Czech Center Digital Genomics
Project in Czech Republic financed by DG Regio

    Statements

    contained in NUTS
    Prague
    0 references
    country
    Czechia
    0 references
    EU contribution
    25,300,500.0 Czech koruna
    0 references
    1,012,020.0 Euro
    exchange rate to Euro
    0.04 Euro
    point in time
    10 January 2020
    0 references
    budget
    50,601,000.0 Czech koruna
    0 references
    2,024,040.0 Euro
    exchange rate to Euro
    0.04 Euro
    point in time
    10 January 2020
    0 references
    co-financing rate
    50 percent
    0 references
    expected end time
    31 March 2020
    0 references
    beneficiary name (string)
    Institute of Applied Biotechnologies a.s.
    0 references
    coordinate location

    50°5'1.93"N, 14°30'28.48"E
    0 references
    postal code
    10800
    0 references
    10800
    0 references
    summary
    Záměrem projektu TGM je vytvoření nového pracoviště pro cílené mapování lidského genomu, které bude sloužit k kolaborativnímu vývoji a klinickému výzkumu nových produktů pro stanovení ranných stádií rakoviny s využitím cirkulujících buněk z krve. Plánujeme zásadním způsobem přispět k rozvoji Theranostiky v ČR, tedy terapie založené na diagnostice, která vede k personalizaci zdravotní péče, zvýšení efektivity a cílené terapie a výrazně snižuje léčebné náklady. a. (Czech)
    0 references

    Identifiers

    Czech Kohesio ID
    CZ.01.1.02/0.0/0.0/17_093/0012409
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q11526&oldid=6596465"